Drug Shortage Report for JAMP-ZOLMITRIPTAN ODT
Report ID | 64290 |
Drug Identification Number | 02428237 |
Brand name | JAMP-ZOLMITRIPTAN ODT |
Common or Proper name | ZOLMITRIPTAN |
Company Name | JAMP PHARMA CORPORATION |
Market Status | DORMANT |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-10-12 |
Estimated end date | 2022-12-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-04-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-04-07 | French | Compare |
v13 | 2021-04-07 | English | Compare |
v12 | 2020-06-19 | French | Compare |
v11 | 2020-06-19 | English | Compare |
v10 | 2020-04-29 | French | Compare |
v9 | 2020-04-29 | English | Compare |
v8 | 2019-07-08 | French | Compare |
v7 | 2019-07-08 | English | Compare |
v6 | 2019-03-01 | French | Compare |
v5 | 2019-03-01 | English | Compare |
v4 | 2018-12-19 | French | Compare |
v3 | 2018-12-19 | English | Compare |
v2 | 2018-10-15 | French | Compare |
v1 | 2018-10-15 | English | Compare |
Showing 1 to 14 of 14